Rocket Lab Corp (NASDAQ:RKLB) pulled back from an all-time highs last month to its mid-October closing high just above $69. The shares subsequently rallied from this low on Friday; an area that’s seven times its opening SPAC level in 2020. Last quarter, short sellers began covering after all-time peaks in short interest. But with 8% of the stock’s total available float, continued short covering could occur in the first few months of 2026. With February implied volatility (IV) just below the stock's 63-day h ...

Power generation stock Generac Holdings Inc (NYSE:GNRC) was last seen up 4.8% at $148.64, after an upgrade from Citigroup to "buy" from "neutral." The firm noted attractive valuation after the stock's recent pivot lower, and kept its price target at $207. This comes one day after BofA Global Research lowered its price target to $224 from $236. On the charts, GNRC has chopped lower since its 4.9% post-earnings drop on Oct. 29, though a recent consolidation at the $138 region could point to underlying support ...

Market Overview - The Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) experienced three consecutive losses due to a mix of Big Tech volatility and economic data, with Oracle's AI-triggered drawdown and Micron Technology's earnings impacting the market [1] - Despite the losses, the Nasdaq Composite (IXIC) and SPX managed to achieve weekly gains [1] Upcoming Economic Reports - A few delayed economic reports, including third-quarter gross domestic product (GDP) data, are expected to be released next week [2] - Historical data suggests that the Friday after Christmas often yields positive returns, indicating a potentially impressive week ahead [2] Historical Performance Data - Since 1950, the SPX has averaged a weekly return of 0.55% during Christmas week, with positive returns occurring almost 70% of the time [3][4] - This year, Christmas falls on a Thursday, a scenario that has occurred only nine times since 1950, with the following Friday averaging a return rate of 0.46% [3][5] Underperforming Stocks - CME Group (CME) is identified as the worst performer during Christmas week, failing to beat SPX returns for at least a decade, with an average return of -0.99% [7][8] - Old Dominion (ODFL) is the only other stock that has not succeeded in beating the SPX during Christmas week in the last 10 years [7] CME Group Analysis - CME Group's stock has struggled, showing a 16% increase in 2025 but a 4% decline in December [8] - The stock has not maintained breakouts above $280, and the 10-week moving average is adding pressure [8] - There is potential for downgrades as eight brokerages currently have a "buy" or better rating, which could lead to further headwinds if bullish sentiment declines [9] Options Trading Strategy - Current options trading conditions for CME Group may present an opportunity, as its Schaeffer's Volatility Index (SVI) of 18% is higher than just 14% of readings from the last year [10] - The Schaeffer's Volatility Scorecard (SVS) indicates that CME has consistently realized lower volatility than its options have priced in, suggesting a premium-selling strategy could be advantageous for options traders [10]

(Bloomberg) — The US stock market is poised to be kept on edge next year as investors are caught between fear of missing out on the artificial-intelligence rally and concern that it’s a bubble just waiting to burst. Big selloffs and quick reversals have been a feature of stock markets for the past 18 months. That trend is likely to continue heading into 2026, with some strategists anticipating that AI will follow the boom-and-bust cycle of past technological revolutions. Most Read from Bloomberg The te ...

Tesla (TSLA) is on another run. It has more than doubled since April, and recently shrugged off a 20% decline. In other words, nothing out of the ordinary for Elon Musk’s $1.6 trillion market cap baby. To say that TSLA is a great trading stock is the understatement of the year. When a stock essentially moves like a 4x ETF, there’s plenty of opportunities to get in. And out, in, and out again. Often all within a matter of months, if not weeks, depending on a trader’s time frame. More News from Barchart ...

Company Overview - Cracker Barrel Old Country Store, Inc. is a prominent American chain that combines restaurant and gift store experiences with a Southern country theme, operating across the United States [1] - The company competes with other casual dining chains such as Denny's and IHOP [1] Recent Trading Activity - On November 28, 2025, Tim Moore, a representative from North Carolina, sold shares of Cracker Barrel valued between $15,001 and $50,000, as part of broader trading activities that included other companies [2][6] - The current stock price of Cracker Barrel is $28.86, reflecting a slight increase of $0.22 or approximately 0.77% [3][6] Stock Performance - Over the past year, Cracker Barrel's stock has experienced significant volatility, with a high of $71.93 and a low of $25.62, indicating sensitivity to market changes and company performance [4][6] - The company's market capitalization is approximately $642.67 million, representing the total market value of its outstanding shares [4] - The trading volume on the NASDAQ exchange for Cracker Barrel is 996,729 shares, indicating the liquidity of the stock [5]

Core Viewpoint - Axon Enterprise is facing significant stock price volatility, with a recent decline of 26.6% over the past month, raising concerns about its high valuation and future performance [2][3][6] Company Performance - On December 3, 2025, the Chief Accounting Officer of Axon sold 74 shares at $536.75 each, leaving her with 14,408 shares [1][6] - The stock price has decreased from $732.23 on October 31, 2025, to $537.75, with a recent slight increase of 1.08% to $543.55 [2][3][6] - The company's market capitalization is approximately $42.89 billion [2] Market Sentiment - Analysts express concerns about Axon's high valuation, suggesting a potential further drop to $377, a level previously reached in the last five years [3] - The trading volume for Axon is 539,276 shares on the NASDAQ, indicating active investor interest despite recent performance [4] Product Offering and Positioning - Axon is recognized as a leader in public-safety technology, with diverse product offerings including the Evidence.com cloud platform and AI-driven video analysis software [5][6] - Despite the high valuation and recent price fluctuations, Axon maintains a strong position in the industry [6]

Core Insights - Several companies have experienced significant stock price declines due to various factors, including company-specific developments and broader market trends [1] Company Summaries - **Black Hawk Acquisition Corporation (NASDAQ:BKHAR)**: The stock price dropped to $0.86, a decrease of approximately 43%. The decline is attributed to the inherent volatility of SPACs, although no specific events were disclosed [2][9] - **Fly-E Group, Inc. (NASDAQ:FLYE)**: The stock price decreased to $9.85, a decline of around 37.6%. This drop may be linked to market reactions regarding the company's financial health and ongoing investigations into potential claims on behalf of long-term shareholders [3][9] - **Janux Therapeutics, Inc. (NASDAQ:JANX)**: The stock price halved to $16.87, reflecting a 50.35% decrease. This significant decline is likely related to updated interim data from its clinical trial for JANX007, impacting investor confidence [4][9] - **Medicus Pharma Ltd. (NASDAQ:MDCXW)**: The stock price fell dramatically by 59.31% to $1.01. The volatility may be connected to developments in its therapeutic assets or regulatory milestones, though specific news is lacking [5] - **Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN)**: The stock price decreased to $1.39, a 55% drop. The decline may be due to setbacks in clinical development, despite recent approval of a business combination that could positively influence the company [6] Industry Observations - The significant price movements in these companies are influenced by factors such as clinical trial results, regulatory actions, financial health, and market sentiment. Biotech firms often experience volatility due to the high-risk nature of drug development, while companies in rapidly evolving sectors like electric mobility are affected by market trends and operational updates [7]

Core Insights - BellRing Brands Inc. (NYSE: BRBR) is recognized for its nutritional products, including protein shakes and bars, and operates in the consumer goods sector [1] - Barclays adjusted its rating for BRBR to "Overweight" while revising its price target from $75 to $50 [3][5] - The stock price of BRBR was $26.26 at the time of the rating adjustment, reflecting a 2.50% increase [5] Trading Activity - Options trading for BRBR saw a notable increase, with 11,860 put options acquired, representing a 274% rise from the average volume of 3,175 put options, indicating hedging against potential downside risks [2][5] - The stock's price fluctuated between $22.45 and $26.34, with a market capitalization of approximately $3.31 billion [2] Analyst Ratings - Analyst opinions on BRBR have been mixed, with Barclays lowering its target price, while Sanford C. Bernstein initiated coverage with an "outperform" rating and a $46 price objective [3] - Jefferies Financial Group raised their target price from $80 to $82, maintaining a "buy" rating, while TD Cowen reduced their price target from $45 to $37 [3] Stock Performance - BRBR's stock has shown significant volatility, with a 52-week high of $80.67 and a low of $22.45 [4] - The trading volume reached 12.97 million shares on the NYSE, indicating strong investor interest despite mixed analyst ratings [4]

Core Insights - Berkshire Hathaway's investment philosophy embraces market volatility as an opportunity rather than a risk, as articulated by CEO Warren Buffett [1][2][3] - The company's transformation from a textile manufacturer to a diversified conglomerate is attributed to strategic asset acquisitions during periods of market turbulence [1][4] Financial Performance - Berkshire's financial results are significantly influenced by its equity holdings and insurance operations, leading to sharp year-to-year earnings fluctuations due to accounting rules [2] - Buffett emphasizes that these earnings swings reflect market sentiment rather than the long-term economic health of the underlying businesses [2] Investment Strategy - Buffett differentiates between volatility and risk, arguing that volatility should not be equated with risk in investment models [3] - The focus is on the durability of cash flows, competitive advantages, and balance-sheet strength, allowing the company to capitalize on price fluctuations [3] Historical Context - Berkshire's portfolio includes investments made during periods of market pessimism, which have yielded substantial gains as market conditions improved [4] - The strategy of enduring mark-to-market declines has been crucial for Berkshire's long-term success in compounding shareholder value [4]